ARDS
Clinical trials for ARDS explained in plain language.
Never miss a new study
Get alerted when new ARDS trials appear
Sign up with your email to follow new studies for ARDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell infusion may help severely ill COVID-19 patients breathe
Disease control TerminatedThis trial tests whether an experimental stem cell therapy called MultiStem can help people with moderate to severe acute respiratory distress syndrome (ARDS) caused by infections like COVID-19. ARDS is a serious lung condition that often requires a breathing tube and ventilator.…
Matched conditions: ARDS
Phase: PHASE2, PHASE3 • Sponsor: Healios K.K. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control TerminatedThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Matched conditions: ARDS
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC